share_log

Tellhow Sci-Tech Co., Ltd.'s (SHSE:600590) Business And Shares Still Trailing The Industry

Tellhow Sci-Tech Co., Ltd.'s (SHSE:600590) Business And Shares Still Trailing The Industry

泰豪科技股份有限公司(SHSE:600590)的業務和股份仍落後於行業板塊。
Simply Wall St ·  06/26 01:13

You may think that with a price-to-sales (or "P/S") ratio of 0.8x Tellhow Sci-Tech Co., Ltd. (SHSE:600590) is a stock worth checking out, seeing as almost half of all the Electrical companies in China have P/S ratios greater than 1.9x and even P/S higher than 4x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.

ps-multiple-vs-industry
SHSE:600590 Price to Sales Ratio vs Industry June 26th 2024

How Has Tellhow Sci-Tech Performed Recently?

Tellhow Sci-Tech could be doing better as its revenue has been going backwards lately while most other companies have been seeing positive revenue growth. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. So while you could say the stock is cheap, investors will be looking for improvement before they see it as good value.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Tellhow Sci-Tech.

Do Revenue Forecasts Match The Low P/S Ratio?

In order to justify its P/S ratio, Tellhow Sci-Tech would need to produce sluggish growth that's trailing the industry.

In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 33%. The last three years don't look nice either as the company has shrunk revenue by 28% in aggregate. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.

Shifting to the future, estimates from the only analyst covering the company suggest revenue should grow by 15% over the next year. That's shaping up to be materially lower than the 23% growth forecast for the broader industry.

In light of this, it's understandable that Tellhow Sci-Tech's P/S sits below the majority of other companies. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.

The Final Word

Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

As we suspected, our examination of Tellhow Sci-Tech's analyst forecasts revealed that its inferior revenue outlook is contributing to its low P/S. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. It's hard to see the share price rising strongly in the near future under these circumstances.

It's always necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Tellhow Sci-Tech, and understanding should be part of your investment process.

If these risks are making you reconsider your opinion on Tellhow Sci-Tech, explore our interactive list of high quality stocks to get an idea of what else is out there.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論